Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Topica Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Topica Pharmaceuticals

Topica Pharmaceuticals

Series C

TOPICA Pharmaceuticals: Developing luliconazole for effective, safe treatment of onychomycosis.

HQ
Palo Alto, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees

Topica Pharmaceuticals is a clinical research stage pharmaceutical company focused on developing luliconazole for treating onychomycosis, a common fungal infection of the nail affecting over 35 million Americans. Luliconazole is noted for its potent antifungal activity, safety profile, and ability to penetrate the nail plate to reach the infection site.

Topica Pharmaceuticals has made significant strides in the development of luliconazole, positioning it as a promising treatment option in a market with limited alternatives. The company's efforts aim to address a significant unmet medical need, potentially improving the quality of life for millions of patients.

Topica Pharmaceuticals - Similar Companies

Hallux logo

Hallux

halluxinc.com

Ansata Therapeutics logo

Ansata Therapeutics

Novelix Pharmaceuticals logo

Novelix Pharmaceuticals

Verrica Pharmaceuticals logo

Verrica Pharmaceuticals

verrica.com

Topicals logo

Topicals

mytopicals.com

Ivrea Pharmaceuticals logo

Ivrea Pharmaceuticals

Izun Pharmaceuticals logo

Izun Pharmaceuticals

izunpharma.com

Aniluxx Biotechnology logo

Aniluxx Biotechnology

aniluxx.com

Neosil logo

Neosil

neosil.com

Quinnova Pharmaceuticals logo

Quinnova Pharmaceuticals

quinnova.com

Transport Pharmaceuticals logo

Transport Pharmaceuticals

Nitric Bio logo

Nitric Bio

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals

tarsusrx.com

Skinvisible logo

Skinvisible

skinvisible.com

Topica Pharmaceuticals - Quick Facts

Who are Topica Pharmaceuticals' competitors?

Companies similar to Topica Pharmaceuticals include Hallux, Ansata Therapeutics, Novelix Pharmaceuticals and Verrica Pharmaceuticals.

When was Topica Pharmaceuticals founded?

Topica Pharmaceuticals was founded in 2004.

Where is Topica Pharmaceuticals' headquarters located?

Topica Pharmaceuticals' headquarters is located in Palo Alto, CA, US.

When was Topica Pharmaceuticals' last funding round?

Topica Pharmaceuticals' most recent funding round was for $31.5M (USD) in June 2013.

How much has Topica Pharmaceuticals raised to-date?

As of Jun 10, 2013, Topica Pharmaceuticals has raised a total of $58.5M (USD).

How many employees does Topica Pharmaceuticals have?

Topica Pharmaceuticals has 11 employees as of Feb 5, 2024.

Topica Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research